Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$0.8256
-0.06-6.99%
At close: -
$0.8212
-0.00440-0.53%
After Hours: 4:14 PM EDT
Comments
Loading...
Context Therapeutics Stock Price, Quotes and Forecasts
CNTXNASDAQ
Context Therapeutics (CNTX) Forecast
NewsEarningsContext Therapeutics (CNTX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Context Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:CNTX | Benzinga
Explore Context Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CNTX.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Context Therapeutics (CNTX) stock?
You can purchase shares of Context Therapeutics (NASDAQ:CNTX) through any online brokerage.
Who are Context Therapeutics (CNTX) competitors?
Other companies in Context Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), Rani Therapeutics Hldgs (NASDAQ:RANI) and Nutriband (NASDAQ:NTRB).
What is the forecast, or price target, for Context Therapeutics (CNTX) stock?
Context Therapeutics has a consensus price target of $6.70.
What is the current price for Context Therapeutics (CNTX)?
The stock price for Context Therapeutics (NASDAQ: CNTX) is $0.8212 last updated March 3, 2025 at 4:14 PM EST.
Does Context Therapeutics (CNTX) pay a dividend?
There are no upcoming dividends for Context Therapeutics.
When is Context Therapeutics (NASDAQ:CNTX) reporting earnings?
Context Therapeutics’s Q1 earnings are confirmed for Wednesday, May 7, 2025.
Is Context Therapeutics (CNTX) going to split?
There is no upcoming split for Context Therapeutics.
What sector and industry does Context Therapeutics (CNTX) operate in?
Context Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.